HOME >> MEDICINE >> NEWS
Cholesterol-lowering drug may slow Alzheimer's progression

NEW ORLEANS, Nov. 9 The cholesterol-lowering drug atorvastatin slowed down mental decline and improved depressive symptoms in people with Alzheimer's disease, according to a small pilot study reported at the American Heart Association's Scientific Sessions 2004.

"This is the first off-label use of a drug tested in Alzheimer's patients in the last 10 years that has shown promise of benefit," said D. Larry Sparks, Ph.D., senior scientist and head of the Roberts Laboratory for Neurodegenerative Disease Research at Sun Health Research Institute in Sun City, Ariz.

Animal and human studies have shown that elevated cholesterol is an important risk factor for Alzheimer's disease. Based on this research and Sparks's work for the past 20 years, he and colleagues in Bethesda, Md., New York City, Phoenix and Sun City, tested the effects of lowering cholesterol in people with mild-to-moderate Alzheimer's disease.

The Alzheimer's Disease Cholesterol-Lowering Treatment Trial (ADCLT) was a double-blind, placebo-controlled pilot study that assessed whether lowering cholesterol with atorvastatin could stabilize or improve cognition in people with mild-to-moderate Alzheimer's. Doctors administered the statin drug in addition to the cholinesterase inhibitors the patients were already taking. Cholinesterase inhibitors are the only Food and Drug Administrationapproved therapy for mild-to-moderate Alzheimer's disease. The drugs inhibit the breakdown of acetylcholine, a transmitter that is decreased in Alzheimer's patients and thought to be related to mental decline.

The researchers evaluated 46 patients -- 25 on atorvastatin 80 mg and 21 on placebo -- for one year. The participants were, on average, 78-years-old with 14 years of education. One-third of the group was female. The patients were evaluated periodically for cognition, overall mental function and depression. Alzheimer's patients are known to have depression that usually gets worse as their Alzheimer
'"/>

Contact: Darcy Spitz
darcy.spitz@heart.org
212-878-5940
American Heart Association
9-Nov-2004


Page: 1 2 3

Related medicine news :

1. Cholesterol-lowering drug may also reduce risk of blood clots
2. Cholesterol-lowering medications may reduce risk of glaucoma
3. Cholesterol-lowering drugs may help stroke patients get well
4. Cholesterol-lowering drugs safe and effective in children
5. Cholesterol-lowering drugs should revolutionise treatment of heart attack and stroke
6. Cholesterol-lowering drugs provide double protection against heart disease
7. Chemical decoy shows promise for slowing Alzheimers by acting as decoy
8. Neuronal death and processing of Tau protein in Alzheimers disease
9. Researchers discover link between insulin and Alzheimers
10. New trials for counseling caregivers and patients with Alzheimers begin
11. Marijuana ingredient may stall decline from Alzheimers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... YORK (PRWEB) , ... July 17, 2019 , ... A ... the Journal of the American Medical Association (JAMA), shows for the first ... sepsis deaths in the state. Sepsis is the body’s extreme response to infection. It ...
(Date:7/17/2019)... ... July 17, 2019 , ... Women’s Excellence is pleased to announce a new office opening in ... The new offices resides on the corner of Turrill Road and South Lapeer Roads, conveniently ... about the opening of our new office in Lapeer and the ability to service women ...
(Date:7/13/2019)... CHICAGO (PRWEB) , ... July 13, 2019 , ... ... its most advanced and innovative rechargeable vibrator and clitoral massager. To view the product ... to offer our newest and most advanced, personal massagers to people around the world,” ...
(Date:7/13/2019)... , ... July 12, 2019 , ... ... YCBD), has been named a “Brand to Watch” by Brightfield Group, a leading ... cbdMD in the top 10 of domestic CBD companies in two categories, Topicals ...
(Date:7/12/2019)... ... July 12, 2019 , ... ... Full Recognition status for its diabetes prevention program from the Centers for Disease ... (DPP) provider to gain full recognition from CDC that delivers the diabetes prevention ...
Breaking Medicine News(10 mins):
(Date:7/19/2019)... ... July 19, 2019 , ... ... acquisition of KSPS Medical Consultants, an office-based opioid treatment (OBOT) program with ... The facility, established in 2014, provides buprenorphine and Suboxone® medication-assisted treatment in ...
(Date:7/19/2019)... WASHINGTON, Pa. (PRWEB) , ... July 19, 2019 ... ... ( AGILE ), a GLC company, has named Jorge Bacigalupo Director of Education ... education practice, which currently includes education delivered on six continents and in ten ...
(Date:7/18/2019)... ... July 18, 2019 , ... Fresh blueberries are now found just ... of homegrown edible berry bushes. , These ornamental berry shrubs, which took more ... any garden or on the patio in containers, not out of sight in the ...
Breaking Medicine Technology:
Cached News: